I have been chatting with another BOT-lady and have realised - once again - how confusing the language used to describe BOTS (and, from what I can tell, all tumours, ovarian or otherwise) are.  As mentioned in previous posts, the naming of BOTS remains controversial (amongst some). A scan of some of the literature and... Continue Reading →